Bionano Genomics, Inc. (BNGO)

NASDAQ: BNGO · Real-Time Price · USD

1.127

+0.007 (0.61%)

Mar 10, 2026, 10:01 AM EDT - Market open

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Diagnostic Kits / Equipment	30.78M	36.12M	27.80M	17.98M	8.50M
Diagnostic Kits / Equipment Growth	-14.79%	29.90%	54.62%	111.47%	-16.06%
Total	30.78M	36.12M	27.80M	17.98M	8.50M
Total Growth	-14.79%	29.90%	54.62%	111.47%	-16.06%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Americas (excl. United States)	8.74M	10.09M	8.04M	5.04M	-
Americas (excl. United States) Growth	-13.44%	25.51%	59.60%	-	-
Europe, The Middle East and Africa (EMEA)	14.23M	12.96M	8.96M	5.60M	3.16M
Europe, The Middle East and Africa (EMEA) Growth	9.80%	44.68%	59.89%	77.17%	-12.81%
Asia Pacific	2.89M	-	-	-	851.00K
United States	4.91M	7.93M	5.82M	4.29M	1.89M
United States Growth	-38.03%	36.19%	35.67%	127.61%	-60.40%
Asia Pacific (Excluding China)	-	4.62M	4.28M	2.71M	-
Asia Pacific (Excluding China) Growth	-	7.87%	57.88%	-	-
China	-	513.30K	697.20K	335.28K	-
China Growth	-	-26.38%	107.95%	-	-
North America (Excl. United States)	-	-	-	-	2.60M
North America (Excl. United States) Growth	-	-	-	-	866.46%
Total	30.78M	36.12M	27.80M	17.98M	8.50M
Total Growth	-14.79%	29.90%	54.62%	111.47%	-16.06%

Source: S&P Global Market Intelligence.